Meta-analysis of randomized controlled trials on magnesium in addition to beta-blocker for prevention of postoperative atrial arrhythmias after coronary artery bypass grafting

BMC Cardiovascular Disorders

Volumn 13, Issue , 2013, Pages

  Wu, Xiaosan ^a   Wang, Congxia ^a   Zhu, Jinyun ^a   Zhang, Chunyan ^a   Zhang, Yan ^a   Gao, Yanhua ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Beta blocker; Magnesium; Meta analysis; Postoperative atrial arrhythmia

Indexed keywords

AMIODARONE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MAGNESIUM; MAGNESIUM SULFATE; PROPRANOLOL; SOTALOL;

ADJUVANT THERAPY; ARTICLE; BRADYCARDIA; CHEMOPROPHYLAXIS; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; DRUG MEGADOSE; HEART ATRIUM ARRHYTHMIA; HUMAN; HYPOTENSION; INCIDENCE; INFORMATION RETRIEVAL; LENGTH OF STAY; LOW DRUG DOSE; MEDLINE; META ANALYSIS; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; RISK ASSESSMENT;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANTI-ARRHYTHMIA AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MAGNESIUM CHLORIDE; MAGNESIUM SULFATE; MALE; MIDDLE AGED; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TACHYCARDIA, SUPRAVENTRICULAR; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872539123     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-13-5     Document Type: Article

References (38)

1. Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 1997, 336:1429-1434. 10.1056/NEJM199705153362006, 9145681.
2. Kim MH, Deeb GM, Morady F, Bruckman D, Hallock LR, Smith KA, Karavite DJ, Bolling SF, Pagani FD, Wahr JA, Sonnad SS, Kazanjian PE, Watts C, Williams M, Eagle KA. Effect of postoperative atrial fibrillation on length of stay after cardiac surgery (The Postoperative Atrial Fibrillation in Cardiac Surgery study [PACS(2)]. Am J Cardiol 2001, 87:881-885. 10.1016/S0002-9149(00)01530-7, 11274944.
3. Lahtinen J, Biancari F, Salmela E, Mosorin M, Satta J, Rainio P, Rimpiläinen J, Lepojärvi M, Juvonen T. Postoperative atrial fibrillation is a major cause of stroke after on-pump coronary artery bypass surgery. Ann Thorac Surg 2004, 77:1241-1244. 10.1016/j.athoracsur.2003.09.077, 15063244.
4. Andrews TC, Reimold SC, Berlin JA, Antman EM. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysisof randomized control trials. Circulation 1991, 84(Suppl III):236-244.
5. Daoud EG, Strickberger SA, Man KC, Goyal R, Deeb GM, Bolling SF, Pagani FD, Bitar C, Meissner MD. Morady F:Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 1997, 337:1785-1791. 10.1056/NEJM199712183372501, 9400034.
6. Marik PE, Fromm R. The efficacy and dosage effect of corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a systematic review. J Crit Care 2009, 24:458-463. 10.1016/j.jcrc.2008.10.016, 19327322.
7. Gold MR, O'Gara PT, Buckley MJ, DeSanctis RW. Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery. Am J Cardiol 1996, 78:975-979. 10.1016/S0002-9149(96)00519-X, 8916473.
8. Wilkes NJ, Mallett SV, Peachey T, Di Salvo C, Walesby R. Correction of ionized plasma magnesium during cardiopulmonary bypass reduces the risk of postoperative cardiac arrhythmia. Anesth Analg 2002, 95:828-834.
9. Parra L, Fita G, Gomar C, Rovira I, Marín JL. Plasma magnesium in patients submitted to cardiac surgery and its influence on perioperative morbidity. J Cardiovasc Surg (Torino) 2001, 42:37-42.
10. England MR, Gordon G, Salem M, Chernow B. Magnesium administration and dysrhythmias after cardiac surgery. A placebo-controlled, double-blind, randomized trial. JAMA 1992, 268:2395-2402. 10.1001/jama.1992.03490170067027, 1404796.
11. Brackbill ML, Moberg L. Magnesium sulfate for prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Am J Health Syst Pharm 2005, 62:397-399.
12. Toraman F, Karabulut EH, Alhan HC, Dagdelen S, Tarcan S. Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2001, 72:1256-1261. 10.1016/S0003-4975(01)02898-3, 11603446.
13. Yeatman M, Caputo M, Narayan P, Lotto AA, Ascione R, Bryan AJ, Angelini GD. Magnesium-supplemented warm blood cardioplegia in patients undergoing coronary artery revascularization. Ann Thorac Surg 2002, 73:112-118. 10.1016/S0003-4975(01)03270-2, 11833996.
14. Miller S, Crystal E, Garfinkle M, Lau C, Lashevsky I, Connolly SJ. Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis. Heart 2005, 91:618-623. 10.1136/hrt.2004.033811, 1768903, 15831645.
15. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999, 354:1896-1900. 10.1016/S0140-6736(99)04149-5, 10584742.
16. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ. Assessing the quality of reports of randomised clinical trials: is blinding necessary?. Control Clin Trials 1996, 17:1-12. 10.1016/0197-2456(95)00134-4, 8721797.
17. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558. 10.1002/sim.1186, 12111919.
18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188. 10.1016/0197-2456(86)90046-2, 3802833.
19. Bert AA, Reinert SE, Singh AK. A beta-blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2001, 15:204-209. 10.1053/jcan.2001.21959, 11312480.
20. Forlani S, De Paulis R, de Notaris S, Nardi P, Tomai F, Proietti I, Ghini AS, Chiariello L. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2002, 74:720-725. 10.1016/S0003-4975(02)03773-6, 12238830.
21. Geertman H, Van Der Starre PJ, Sie HT, Beukema WP, van Rooyen-Butijn M. Magnesium in addition to sotalol does not influence the incidence of postoperative atrialtachyarrhythmias after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2004, 18:309-312. 10.1053/j.jvca.2004.03.010, 15232810.
22. Cook RC, Humphries KH, Gin K, Janusz MT, Slavik RS, Bernstein V, Tholin M, Lee MK. Prophylactic intravenous magnesium sulphate in addition to oral beta-blockade does not preventatrial arrhythmias after coronary artery or valvular heart surgery: a randomized, controlled trial. Circulation 2009, 120(Suppl):S163-S169. 10.1161/CIRCULATIONAHA.108.841221, 19752363.
23. Solomon AJ, Berger AK, Trivedi KK, Hannan RL, Katz NM. The combination of propranolol and magnesium does not prevent postoperative atrial fibrillation. Ann Thorac Surg 2000, 69:126-129. 10.1016/S0003-4975(99)01187-X, 10654500.
24. Forlani S, Moscarelli M, Scafuri A, Pellegrino A, Chiariello L. Combination therapy for prevention of atrial fibrillation after coronary artery bypass surgery: a randomized trial of sotalol and magnesium. Card Electrophysiol Rev 2003, 7:168-171. 10.1023/A:1027423802701, 14618045.
25. Allen LA, Magid DJ, Zeng C, Peterson PN, Clarke CL, Shetterly S, Brand DW, Masoudi FA. Patterns of beta-blocker intensification in ambulatory heart failure patients and short-term association with hospitalization. BMC Cardiovasc Disord 2012, 12:43. 10.1186/1471-2261-12-43, 3413533, 22709128.
26. Lauer MS, Eagle KA, Buckley MJ, DeSanctis RW. Atrial fibrillation following coronary artery bypass surgery. Prog Cardiovasc Dis 1989, 31:367-378. 10.1016/0033-0620(89)90031-5, 2646657.
27. Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, VanderVliet M, Collins JJ, Cohn LH, Burstin HR. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996, 94:390-397. 10.1161/01.CIR.94.3.390, 8759081.
28. Teo KK, Yusuf S, Collins R, Held PH, Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ 1991, 303:1499-1503. 10.1136/bmj.303.6816.1499, 1671862, 1838289.
29. Colquhoun IW, Berg GA, el-Fiky M, Hurle A, Fell GS, Wheatley DJ. Arrhythmia prophylaxis after coronary artery surgery. A randomised controlled trial of intravenous magnesium chloride. Eur J Cardiothorac Surg 1993, 7:520-523. 10.1016/1010-7940(93)90049-H, 8267992.
30. Dagdelen S, Toraman F, Karabulut H, Alhan C. The value of P dispersion on predicting atrial fibrillation after coronary artery bypass surgery: effect of magnesium on P dispersion. Ann Noninvasive Electrocardiol 2002, 7:211-218. 10.1111/j.1542-474X.2002.tb00165.x, 12167181.
31. Karmy-Jones R, Hamilton A, Dzavik V, Allegreto M, Finegan BA, Koshal A. Magnesium sulfate prophylaxis after cardiac operations. Ann Thorac Surg 1995, 59:502-507. 10.1016/0003-4975(94)00895-E, 7847975.
32. Kaplan M, Kut MS, Icer UA, Demirtas MM. Intravenous magnesium sulfate prophylaxis for atrial fibrillation after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2003, 125:344-352. 10.1067/mtc.2003.108, 12579104.
33. Parikka H, Toivonen L, Pellinen T, Verkkala K, Järvinen A, Nieminen MS. The influence of intravenous magnesium sulphate on the occurrence of atrial fibrillation after coronary artery by-pass operation. Eur Heart J 1993, 14:251-258. 10.1093/eurheartj/14.2.251, 8449202.
34. Caspi J, Rudis E, Bar I, Safadi T, Saute M. Effects of magnesium on myocardial function after coronary artery bypass grafting. Ann Thorac Surg 1995, 59:942-947. 10.1016/0003-4975(95)00050-U, 7695422.
35. Jensen BM, Alstrup P, Klitgård NA. Magnesium substitution and postoperative arrhythmias in patients undergoing coronary artery bypass grafting. Scand Cardiovasc J 1997, 31:265-269. 10.3109/14017439709069546, 9406292.
36. Treggiari-Venzi MM, Waeber JL, Perneger TV, Suter PM, Adamec R, Romand JA. Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery. Br J Anaesth 2000, 85:690-695. 10.1093/bja/85.5.690, 11094581.
37. Kulick DL, Hong R, Ryzen E, Rude RK, Rubin JN, Elkayam U, Rahimtoola SH, Bhandari AK. Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac disease. Am Heart J 1988, 115:367-373. 10.1016/0002-8703(88)90483-8, 3341171.
38. The Cochrane Collaboration: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] Higgins JPT, Green S, http://www.cochrane-handbook.org.